A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages

Area of Science:

• Cell Biology
• Immunology
• Molecular Oncology

Background:

• p185neu is a receptor tyrosine kinase implicated in various cancers.
• The regulation of p185neu activity is crucial for understanding cancer progression.
• Macrophages are immune cells with diverse signaling capabilities.

Purpose of the Study:

• To identify potential ligands produced by activated macrophages that regulate p185neu.
• To characterize the nature and function of such a ligand.
• To investigate the mechanism of p185neu down-regulation.

Main Methods:

• Utilized muramyl dipeptide (MDP)-activated macrophage-conditioned medium (MDP-CM).
• Employed NIH3T3 cells expressing p185neu for functional assays.
• Applied a ligand-trapping approach using secreted, soluble NEU protein.
• Purified the soluble NEU protein via affinity chromatography.
• Analyzed protein interactions using Western blotting.

Main Results:

• MDP-CM induced dose-dependent and temperature-sensitive p185neu down-regulation.
• A truncated, soluble NEU protein preparation blocked MDP-CM-induced p185neu down-regulation and reduced self-phosphorylation.
• Identified a 25 kDa polypeptide in MDP-CM that binds to soluble NEU.
• This 25 kDa ligand is distinct from known growth factors like EGF, PDGF, FGF, IGF, TGF-α, TGF-β, and TNF-α.

Conclusions:

• Macrophages activated by MDP produce a novel, p185neu-specific ligand.
• This 25 kDa ligand directly interacts with p185neu, leading to its down-regulation.
• The findings suggest a new pathway for regulating p185neu in biological systems.